Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedPhase 1/2

NCT02540356

Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer

The purpose of this study is to evaluate the safety and tolerability of BAX69 monotherapy given either as intraperitoneal (IP) infusion (Single-Route Arm); or a…

United States2 participantsStarted 2015-11-02

Treatment: BAX69 Single-Route Arm, BAX69 Double-Route Arm